The Food and Drug Administration approved updated versions of COVID-19 vaccines on Monday, a key step in getting the new shots to Americans as early as this week.
Why it matters: The Biden administration has faced increasing calls to make the reformulated vaccines available more quickly as infections and hospitalizations ticked up in recent weeks.
Driving the news: The FDA greenlit shots from Pfizer and Moderna that are targeted against the XBB.1.5 variant, which was the dominant strain circulating in the United States earlier this summer.
Of note: Health officials expect that COVID shots will be updated every fall to account for circulating variants, similar to the schedule for annual flu shots.